These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4797454)

  • 1. Proceedings: Dopamine neurones and electrical self-stimulation in the lateral hypothalamus.
    Christie JE; Ljungberg T; Ungerstedt U
    J Physiol; 1973 Oct; 234(2):80P-81P. PubMed ID: 4797454
    [No Abstract]   [Full Text] [Related]  

  • 2. The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine.
    Costall B; Naylor RJ; Pycock C
    J Pharm Pharmacol; 1975 Dec; 27(12):943-6. PubMed ID: 2668
    [No Abstract]   [Full Text] [Related]  

  • 3. Reinstatement of eating by dopamine agonists in aphagic dopamine denervated rats.
    Ljungberg T; Ungerstedt U
    Physiol Behav; 1976 Mar; 16(3):277-83. PubMed ID: 1033572
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Interaction of neuroleptic and cholinergic drugs with central dopaminergic mechanisms.
    Kelly P; Miller RJ; Sahakian B
    Br J Pharmacol; 1974 Nov; 52(3):430P-431P. PubMed ID: 4477511
    [No Abstract]   [Full Text] [Related]  

  • 5. A role for dopamine in the psychopharmacology of electrical self-stimulation of the lateral hypothalamus, substantia nigra, and locus coeruleus.
    Cooper BR; Breese GR
    Psychopharmacol Bull; 1975 Jul; 11(3):30-1. PubMed ID: 1153654
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Mechanisms involved in the effect of apomorphine on the extrapyramidal system of the rat.
    Loew DM; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R10. PubMed ID: 1170505
    [No Abstract]   [Full Text] [Related]  

  • 7. Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: quantification using the rotational model.
    Marshall JF; Ungerstedt U
    Eur J Pharmacol; 1977 Feb; 41(4):361-7. PubMed ID: 557411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of the melanostatin analogue alaptide on dopamine-dependent behavior in rats reared in isolation].
    Lebedev AA; Panchenko GN; Shabanov PD
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2000; 50(4):716-9. PubMed ID: 10984916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ingestive behavior following damage to central dopamine neurons: implications for homeostasis and recovery of function.
    Zigmond MJ; Stricker EM
    Adv Biochem Psychopharmacol; 1974; 12(0):385-402. PubMed ID: 4609140
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of dopaminergic denervation on Na+-K+ ATPase activity and 3H-ouabain binding in rat corpus striatum.
    Bjur RA; Westfall DP
    Proc West Pharmacol Soc; 1984; 27():35-8. PubMed ID: 6093132
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Electrical self-stimulation with electrodes in the region of the interpeduncular nucleus.
    Anlezark GM; Arbuthnott GW; Christie JE; Crow TJ
    J Physiol; 1973 Oct; 234(2):103P-104P. PubMed ID: 4767030
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denervation in the dopaminergic mesolimbic system: functional changes followed using (-)N-n-propylnorapomorphine depend on the basal activity levels of rats.
    Costall B; Hui SC; Naylor RJ
    Neuropharmacology; 1980 Nov; 19(11):1039-48. PubMed ID: 7192370
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Behavioral effects of direct and indirect acting dopaminergic agonists.
    Moore KE
    Psychopharmacol Bull; 1974 Jul; 10(3):41-2. PubMed ID: 4419323
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of apomorphine on self-stimulation behavior.
    Broekkamp CL; van Rossum JM
    Psychopharmacologia; 1974 Jan; 34(1):71-80. PubMed ID: 4816729
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential behavioral activities from anterior and posterior hypothalamic lesions in the rat.
    Rondeau DB; Jolicoeur FB; Belanger F; Barbeau A
    Pharmacol Biochem Behav; 1978 Jul; 9(1):43-7. PubMed ID: 568291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopaminergic modulation of lateral hypothalamic self-stimulation.
    Neill DB; Parker SD; Gold MS
    Pharmacol Biochem Behav; 1975; 3(3):485-91. PubMed ID: 1153452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of apomorphine to induce dopaminergic hypersensitivity: a replication.
    Flemenbaum A
    Prog Clin Biol Res; 1981; 68():143-9. PubMed ID: 7197786
    [No Abstract]   [Full Text] [Related]  

  • 19. Linear increments in behavioral perseveration induced by repeated apomorphine administration.
    Carey RJ
    Biol Psychiatry; 1983 Feb; 18(2):249-53. PubMed ID: 6681990
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist.
    Jaton AL; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Mar; 56(3):371P. PubMed ID: 944059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.